Common and Uncommon Features of Rheumatoid Arthritis and Chronic Obstructive Pulmonary Disease: Clues to a Future Therapy
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
4
Page:
85-92
Author(s):
E. Andreakos
Prevention of Endothelial Cell Injury by Activated Protein C: The Molecular Mechanism(s) and Therapeutic Implications
Journal:
Current Vascular Pharmacology
Volume:
2
Page:
125-133
Author(s):
Kenji Okajima
The Role of Vascular Cell Senescence in Atherosclerosis: Antisenescence as a Novel Therapeutic Strategy for Vascular Aging
Journal:
Current Vascular Pharmacology
Volume:
2
Page:
141-148
Author(s):
Tohru Minamino, Hideyuki Miyauchi, Toshihiko Yoshida, Kaoru Tateno and Issei Komuro
Passive Smoking and Coronary Heart Disease
Journal:
Current Vascular Pharmacology
Volume:
2
Page:
175-182
Author(s):
Aurelio Leone, Danilo Giannini, Chiara Bellotto and Alberto Balbarini
The Rise and Fall of NMDA Antagonists for Ischemic Stroke
Journal:
Current Molecular Medicine
Volume:
4
Page:
131-136
Author(s):
L. Hoyte, P. A. Barber, A. M. Buchan and M. D. Hill
Pharmacotherapy for Intermittent Claudication: From Consensus-Based to Evidence-Based Treatment
Journal:
Vascular Disease Prevention (Discontinued)
Volume:
1
Page:
1-15
Author(s):
Roberto Antonio Mangiafico and Carmelo Erio Fiore
Prevention of Cardiovascular Complications in the Marfan Syndrome
Journal:
Vascular Disease Prevention (Discontinued)
Volume:
1
Page:
79-86
Author(s):
L. J. Meijboom, G. J. Nollen and B. J.M. Mulder
Endothelial Dysfunction and Coronary Atherosclerosis
Journal:
Current Drug Targets - Cardiovascular & Hematological Disorders
Volume:
4
Page:
13-22
Author(s):
Shiro Kitamoto and Kensuke Egashira
Current Understanding of In-stent Restenosis and the Potential Benefit of Drug Eluting Stents
Journal:
Current Drug Targets - Cardiovascular & Hematological Disorders
Volume:
4
Page:
103-117
Author(s):
M. Froeschl, S. Olsen, X. Ma and E. R. O'Brien
Selectins as Targets in Inflammatory Diseases
Journal:
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume:
3
Page:
31-38
Author(s):
Henrik Thorlacius